Orthostatic Hypotension Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

  • Single User License $3500

Orthostatic Hypotension Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Status : March, 2020 | Pharmaceutical | PPT format

Report Digest


Global Orthostatic Hypotension Drugs Market: Overview

The global orthostatic hypotension drugs market is expanding at the back of improvements in blood pressure management tools and equipment. Medical research revolves around developing workable solutions to improve the health standards of the people. Furthermore, the interrelation between various types of diseases necessitates a proper system of diagnosis within healthcare. Several reasons can be responsible for abrupt cycles of low blood pressure. Hence, the global orthostatic hypotension drugs market has a large consumer base at its disposal. The rising incidence of cardiovascular diseases has also driven market demand.

Increase in the geriatric population can be considered a key driver of demand within the global orthostatic hypotension drugs market. People aged above sixty are at a greater risk of suffering from cardiovascular diseases, and a large section this population requires adequate dosage of drugs to control blood pressure and regulate blood circulation. It is expected that the growing spending in the domain of cardiovascular treatments would drive market demand. Several other factors including excessive immobility and lack of exercise can be responsible for hypotension.

Heart failure and irregular heart rhythms have become two of the most common problems in aging individuals. These conditions are often accompanied or followed by the incidence of orthostatic hypotension. Medical professionals emphasize on the need for caution with drug dosage amongst cardiac patients. Therefore, the market shall increase in size and revenues in the years to follow.

A review on the global orthostatic hypotension drugs market reveals key dynamics of market growth. The global orthostatic hypotension drugs market can be segmented on the basis of the following parameters: product and region. Based on the type of product, the demand for northera is projected to increase in the years to follow.

Global Orthostatic Hypotension Drugs Market: Notable Developments

  • La Jolla Pharmaceutical has emerged as a key player in the global market. The shares of the company ticked-up by 5% as the EU approved the use of Giapreza, a hypotension drug developed by LJPC. Such approvals have played an integral role in driving demand within the global orthostatic hypotension drugs market. Furthermore, gaining approvals from the EU, FDA, and other key bodies is a huge success for market vendors.
  • Pfizer Inc. is a prominent supplier of orthostatic hypotension drugs across the globe. The company does not follow direct promotion strategies to sell its products. Instead, Pfizer promotes positive messages around human health to generate congeniality around drug use.

Some of the leading vendors in the global orthostatic hypotension drugs market are:

  • Amneal Pharmaceuticals Inc.
  • Mylan NV
  • H. Lundbeck AS
  • Novartis AG

Global Orthostatic Hypotension Drugs Market: Growth Drivers

  • Rising Incidence of Anaemia and Parkinson’s Disease

The global incidence of Parkinson’s disease has created an array of growth opportunities across the orthostatic hypotension drugs market. Furthermore, the incidence of anaemia in middle-aged persons has increased in recent times. This factor, coupled with the need for proper treatment of diabetes and thyroid, has paved way for market growth.

  • Need to Prevent Alleviated Blood Pressure in Children and Pregnant Women

Pregnancy can subject women to multiple cycles of blood pressure fluctuations. Hence, the use of orthostatic hypotension drugs in the field of gynaecology has increased in recent times. Furthermore, children may suffer from hypotension due to excessive dehydration and strenuous activity. It is, therefore, evident that the orthostatic hypotension drugs market caters to all age groups.

The global orthostatic hypotension drugs market is segmented as:

Product

  • Midodrine
  • Northera (droxidopa)
  • Fludrocortisone
  • Other drugs

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.

Wish to check Table of Contents of this report?

Click below to Request TOC

Request TOC